Debate: Should DLBCL Patients be Treated Differently Based on Cell of Origin? - No - 100004

Spotlight
Video

Debate: Should DLBCL Patients be Treated Differently Based on Cell of Origin? - No

imedex has 1322 videos Subscribe Here

Loading........
Description: Filmed on location in New York during the Great Debates & Updates in Hematologic Malignancies 2015, this webcast is part of a series that focuses on controversial areas in the management of hematologic malignancies as nationally-recognized thought leaders take opposing sides on topics of clinical interest.

In this presentation, Dr. Peter Martin argues that Diffuse Large B-Cell Lymphoma (DLBCL) patients should not be treated differently today based on cell of origin (Germinal vs. Non-Germinal Center).


© 2015 Imedex, LLC.
Shared By : imedex
Posted on : 10/22/15
Added : 4 years ago
Category : Lymphoma